Tank-binding kinase inhibitor compounds

Compounds having the following formula (I) and the acceptable salt, the prodrug, the biological active metabolite, the stereisomer and the isomeride on the pharmacy are provided by the invention, wherein the variables are defined by the invention. The compound is useful for the treatment immunity an...

Full description

Saved in:
Bibliographic Details
Main Authors ZABLOCKI JEFF, WATKINS WILLIAM J, GUERRERO JUAN ARNALDO, DU ZHIMIN, KNOX JR JOHN EDWARD, VENKATARAMANI CHANDRASEKAR, KAPLAN JOSHUA AARON, NADUTHAMBI DEVAN, PHILLIPS BARTON W, WANG PEIYUAN
Format Patent
LanguageChinese
English
Published 22.02.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compounds having the following formula (I) and the acceptable salt, the prodrug, the biological active metabolite, the stereisomer and the isomeride on the pharmacy are provided by the invention, wherein the variables are defined by the invention. The compound is useful for the treatment immunity and the cancer disease. 本发明提供了具有化学式(I)的化合物、其药学上可接受的盐、前药、生物活性代谢物、立体异构体及异构体，其中这些变量是本文中所定义的。本发明的这些化合物对于治疗免疫性和癌症性病症是有用的。
Bibliography:Application Number: CN201580031633